The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: Evaluation by the new SPECT-ligand [99mTc] TRODAT-1

Journal of Psychopharmacology

Volumn 19, Issue 5, 2005, Pages 488-493

  Schmitt, G J E ^a   Meisenzahl, Eva M ^a   Frodl, T ^a   La Fougere C ^a   Hahn, K ^a   Moller H J ^a   Dresel, S ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

99mTc TRODAT 1; Drug naive; First episode; Schizophrenia; SPECT; Striatal dopamine transporter

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; ANTIDEPRESSANT AGENT; DOPAMINE TRANSPORTER; LIGAND; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEMOGRAPHY; DOPAMINERGIC ACTIVITY; FEMALE; HUMAN; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ACUTE DISEASE; ADULT; ANALYSIS OF VARIANCE; BINDING, COMPETITIVE; BRIEF PSYCHIATRIC RATING SCALE; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; INPATIENTS; MALE; ORGANOTECHNETIUM COMPOUNDS; PROTEIN BINDING; RADIOLIGAND ASSAY; SCHIZOPHRENIA, PARANOID; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 25844448573     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105056530     Document Type: Article

References (39)

1. Abi-Dargham A, Gil R, Krystal J, Baldwin R M, Seibyl J P, Bowers M, van Dyck C H, Charney D S, Innis R B, Lamelle M (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155(6): 761-767
2. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles L S, Weiss R, Cooper T B, Mann J J, Van Heertum R L, Gorman J M, Laruelle M (2000) Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 97(14): 8104-8109
3. Bannon M J, Sacchetti P, Granneman J G (2000) The dopamine transporter: potential involvement in neuropsychiatric disorders. In Bloom K (ed.), Psychopharmacology. The Fourth Generation of Progress, online edition. Raven Press
4. Bannon M J, Michelhaugh S K, Wang J, Sacchetti P (2001) The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacol 11: 449-455
5. Breier A, Su T P, Saunders R, Carson R E, Kolachana B S, de Bartolomeis A, Weinberger D R, Weisenfeld N, Malhotra A K, Eckelman W C, Pickar D (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94(6): 2569-2574
6. Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20: 140-144
7. Ciliax B J, Heilman C, Demechyshyn L L, Pristupa Z B, Ince E, Hersch S M, Niznik H B, Levey A I (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15: 1714-1723
8. Dao-Castellana M H, Paillere-Martinot M L, Hantraye P, Attar-Levy D, Remy P, Crouzel C, Artiges E, Feline A, Syrota A, Martinot J L (1997) Presynaptic dopaminergic function in the striatum of schizophrenic patients. Schizophr Res 23(2): 167-174
9. Dean B, Hussain T (2001) Studies on dopaminergic and GABAergic markers in striatum reveals a decrease in the dopamine transporter in schizophrenia. Schizophrenia Research 52: 107-114
10. 99mTc]TRODAT-1 to the central dopamine transporter in rats. Eur J Nucl Med 25: 31-39
11. Dresel S H, Kung M P, Huang X F, Plossl K, Hou C, Meegalla S K, Patselas G, Mu M, Saffer J R, Kung H F (1999) Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons. J Nucl Med 40: 660-666
12. 99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 27: 1518-1524
13. 99mTc]TRODAT-1: Scintigraphic characterization of the cerebral striatal dopamine transporter in healthy volunteers, patients with schizophrenia, and patients with attention deficit hyperactivity disorder. Thesis from the Department of Nuclear Medicine, LMU-University of Munich, Germany
14. Heinz A, Saunders R C, Kolachana B S, Jones D W, Gorey J G, Bachevalier J, Weinberger D R (1999) Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage. Synapse 32: 71-79
15. Hietala J, Syvalahti E, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, Solin O, Kuoppamaki M, Kirvela O, Ruotsalainen U, et al (1995) Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 346(8983): 1130-1131
16. Hsiao M C, Lin K J, Liu C Y, Tzen K Y, Yen T C (2003) Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99 m Tc-TRODAT-1. Schizophr Res 65: 39-16
17. Knable M B, Hyde T M, Herman M M, Carter J M, Bigelow L, Kleinman J E (1994) Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients. Biol Psychiatry 30(12): 826-835
18. Krause K H, Dresel S H, Krause J, Kung H F, Tatsch K (2000) Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neuroscience Letters 285: 107-110
19. Kuikka J T, Tiihonen J, Karhu J, Bergström K A, Räsänen P (1997) Fractal analysis of striatal dopamine re-uptake sites. Eur J Nucl Med 24: 1085-1090
20. Kung H F (2001) Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent. Nucl Med Biol 28: 505-508
21. Laakso A, Vilkman H, Alakare B, Haaparanta M, Bergman J, Solin O, Peurasaari J, Räkköläinen V, Syvalahti E, Hietala H (2000) Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. Am J Psychiatry 157: 269-271
22. Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Syvälahti E, Hietala H (2001) Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophrenia Res 52: 115-120
23. Laruelle M, D'Souza C D, Baldwin R M, Abi-Dargham A, Kanes S J, Fingado C L, Seibyl J P, Zoghbi S S, Bowers M B, Jatlow P, Charney D S, Innis R B (1997) Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 77(3): 162-174
24. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R (1999) Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46(1): 56-72
25. Laruelle M, Abi-Dargham A, van Dyck C, Gil R, D'Souza D C, Krystal J, Seibyl J, Baldwin R, Innis R (2000) Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [123I]β-CIT. Biol Psychiatry 47: 371-379
26. Lavalaye J, Booij J, Reneman L, Habraken J B A, van Royen E A (2000) Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med 27: 867-869
27. Lavalaye J, Linszen D H, Booij J, Dingemans P M A J, Reneman L, Habraken J B A, Gersons B P R, van Royen E A (2001) Dopamine transporter density in young patients with schizophrenia assessed with [123I]FP-CIT SPECT. Schizophrenia Res 47: 59-67
28. Lindstrom L H, Gefvert O, Hagberg G, Lundberg T, Bergstrom M, Hartvig P, Langstrom B (1999) Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET. Biol Psychiatry 46(5): 681-688
29. 99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys. Nucl Med Biol 29: 561-567
30. Meegalla S K, Plössl K, Kung M-P, Chumpradit S, Stevenson D A, Kushner S A, McElgin W T, Mozley P D, Kung H F (1997) Synthesis and characterization of Tc-99m labeled tropanes as dopamine transporter imaging agents. J Med Chem 40: 9-17
31. 99mTc]TRODAT-1 as dopamine transporter imaging agents. J Med Chem 41: 428-436
32. Mozley P, Stubbs J, Plössl K, Dresel S, Barraclough E, Alavi A, Araujo L, Kung H (1998) Biodistribution and dosimetry of TRODAT-1: A technetium-99m tropane for imaging dopamine transporters. J Nucl Med 39: 2069-2076
33. Mozley P, Acton P D, Barraclough E D, Plössl K, Gur R C, Alavi A, Mathur A, Saffer J, Kung H F (1999) Effects of age on dopamine transporters in healthy humans. J Nucl Med 40: 1812-1817
34. Mozley L H, Gur R C, Mozley P D, Gur R E (2001) Striatal dopamine transporters and cognitive functioning in healthy men and women. Am J Psychiatry 158: 1492-1499
35. Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F, Bachneff S, Cumming P, Diksic M, Dyve S E, Etienne P, Evans A C, Lal S, Shevell M, Savard G, Wong D F, Chouinard G, Gjedde A (1994) Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci USA 91(24): 11651-11654
36. Rivest R, Falardeau P, Di Paolo T (1995) Brain dopamine transporter: gender differences and effect of chronic haloperidol. Brain Res 692: 269-272
37. Sjoholm H, Bratlid T, Sundsfjord J (2004) 1231-beta-CIT SPECT demonstrates increased presynaptic dopamine transporter binding sites in basal ganglia in vivo in schizophrenia. Psychopharmacology 173: 27-31
38. 123I]β-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 41: 275-284
39. 3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. Am J Psychiatry 161: 1496-1498